TINA ANDREWS: Open Payments
NPI 1528580479 · IMPERIAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $54 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Tris Pharma Inc | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, PREVNAR 20, Ozempic, FARXIGA, CAPLYTA, Dyanavel XR, UBRELVY, JARDIANCE.
Industry payments across MO — which companies pay providers there.
